Wolverine Blend (BPC-157 + TB-500) 30mg — Vial Spec, Reconstitution Math & COA

Overview and Molecular Specification of the 30mg Format

The Wolverine Blend 30mg configuration is engineered for extended, multi-assay laboratory protocols that require high mass volumes of both BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 synthetic fragment). In a standard 1:1 formulation, a 30mg vial contains 15mg of BPC-157 sequence and 15mg of TB-500 sequence, sterile-filled and lyophilized into a stable peptide cake.

While PX1 Research maintains stock of standard catalog sizes such as the Wolverine Blend 10mg (5mg/5mg) for standard assay scales, the 30mg high-capacity vial is primarily requested by high-throughput facilities or animal model cohorts requiring consistent lot-matched dosing across extended research timelines. Investigators looking for alternative configurations or single-agent controls can explore our full catalog via all peptides.

It is essential for laboratory personnel to recognize that working with a 30mg combined lyophilized mass requires strict volume planning during reconstitution. Because two distinct primary peptide chains reside in the same matrix, total dissolved mass concentration must be accounted for when calculating liquid displacement and pipette precision in cellular and tissue assays.

High-Throughput Protocol Selection: 30mg vs. Standard Catalog Sizes

Selecting between a 30mg high-mass vial and smaller standard sizes (such as 5mg or 10mg total blend vials) depends primarily on experimental design, subject pool size, and desired reconstituted stability windows. A 30mg format significantly reduces vial-to-vial variability across large preclinical animal cohorts by enabling a single, unified reconstitution event.

However, large-format vials require rigorous aliquot planning to prevent repeated freeze-thaw cycles once dissolved. For smaller pilot studies, in vitro cell cultures, or single-timepoint assays, standard smaller vials or separate single-component controls may offer greater flexibility and reduced waste.

When purchasing high-mass configurations for enterprise research, laboratories often coordinate bulk acquisitions through our specialized wholesale portal to ensure dedicated lot reservations, synchronized analytical documentation, and custom volume scheduling.

Synergistic Preclinical Mechanisms: BPC-157 and TB-500 Co-Culture

In preclinical literature, BPC-157 is characterized as a pentadecapeptide derived from human gastric juice sequence, extensively evaluated for its role in modulating vascular endothelial growth factor (VEGF) expression, focal adhesion kinase signaling, and nitric oxide pathway activity. Preclinical animal models demonstrate its capacity to influence tendon-to-bone integration, fibroblast proliferation, and cellular migration under ischemic or mechanical stress.

Concurrently, TB-500 represents a functional synthetic peptide sequence corresponding to the active domain of Thymosin Beta-4. Preclinical assays show that TB-500 sequesters G-actin, promoting actin polymerization, cell motility, and microvascular sprouting in dermal and musculoskeletal tissue repair models.

When evaluated together in dual-agent preclinical models, the combination exhibits complementary activity: BPC-157 modulates early-phase local signaling and receptor expression, while TB-500 facilitates cytoskeleton remodeling and cell movement across the extracellular matrix. Research teams investigating tissue regeneration and structural repair frequently deploy this dual formulation to analyze potential additive or synergistic cell-signaling cascades.

Reconstitution Mathematics for a 30mg Combined Lyophilized Mass

Accurate reconstitution of a 30mg total peptide mass requires careful calculation of final liquid concentration. The total mass (30mg) contains 15mg of BPC-157 and 15mg of TB-500. Standard diluents include Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on downstream cellular sensitivity.

The mathematical formula to determine total peptide concentration per milliliter is: Concentration (mg/mL) = Total Mass (30mg) / Reconstitution Volume (mL). To determine individual component concentrations, divide individual mass (15mg) by volume:

• 1.0 mL Diluent Addition: Total concentration = 30.0 mg/mL. Individual concentrations = 15.0 mg/mL BPC-157 + 15.0 mg/mL TB-500. Yields 3.0 mg total peptide per 0.1 mL (100 µL).

• 2.0 mL Diluent Addition: Total concentration = 15.0 mg/mL. Individual concentrations = 7.5 mg/mL BPC-157 + 7.5 mg/mL TB-500. Yields 1.5 mg total peptide per 0.1 mL (100 µL).

• 3.0 mL Diluent Addition: Total concentration = 10.0 mg/mL. Individual concentrations = 5.0 mg/mL BPC-157 + 5.0 mg/mL TB-500. Yields 1.0 mg total peptide per 0.1 mL (100 µL).

For complex dilution schemes, micro-gram conversions, or custom research concentrations, scientists are advised to utilize our interactive reconstitution calculator to verify laboratory math before liquid handling.

Aliquot Strategy and Handling Protocols

Because reconstituted peptides undergo progressive hydrolysis and potential aggregation if maintained in liquid phase at refrigerated temperatures over extended periods, a 30mg vial should be sub-aliquoted immediately following initial reconstitution.

Using sterile, low-binding polypropylene microcentrifuge tubes, divide the reconstituted 30mg solution into single-use volumetric fractions tailored to daily assay needs. Each aliquot should be flash-frozen at -20°C or -80°C. Individual aliquots are thawed only once prior to immediate application in vitro or in animal models.

Avoiding repeated freeze-thaw cycles preserves secondary peptide structure, prevents physical precipitation, and ensures uniform compound potency across multi-week experimental series.

Storage Parameters and Stability Guidelines

Lyophilized Wolverine Blend 30mg vials should be stored upon receipt in a temperature-monitored freezer at -20°C or below, protected from light exposure. In dry lyophilized form under inert gas atmosphere, the dual-peptide matrix remains stable for up to 24 months without significant degradation.

Following reconstitution with bacteriostatic diluent, the master vial or working aliquots may be stored at 2°C to 8°C for short-term evaluation (up to 14–21 days). If reconstituted with unpreserved sterile water or saline, aliquots must be used immediately or stored frozen at -20°C to prevent bacterial growth and enzymatic cleavage.

Researchers can reference deeper storage and stability literature within our comprehensive research library to establish standardized operating procedures for laboratory personnel.

Analytical Purity Verification & Lot-Matched COA Integrity

PX1 Research subjects every batch of Wolverine Blend to rigorous analytical testing in ISO 17025 accredited, independent laboratories. Because dual-peptide formulations contain two distinct active sequences, analytical testing must confirm both individual purity and accurate mass ratios.

High-Performance Liquid Chromatography (HPLC) is conducted to verify that total chromatographic purity exceeds 99%, with clear baseline resolution between the BPC-157 and TB-500 peaks. Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the exact molecular weights of both pentadecapeptide and thymosin fragment structures.

Furthermore, every lot undergoes Chromogenic LAL Endotoxin Testing to ensure levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or rodent models. Researchers can review and download verified lot-matched documentation directly via our COA lookup portal.

Comparative Analysis in the Repair and Regeneration Cluster

Within the strength and tissue repair research cluster, investigators frequently compare the Wolverine Blend against other active peptide sequences. While Wolverine Blend combines BPC-157 and TB-500 to target collagen cross-linking and actin dynamics, compounds such as GHK-Cu operate through copper-dependent gene modulation and extracellular matrix gene upregulation.

In metabolic and musculoskeletal crossover studies, researchers may also evaluate growth hormone secretagogues alongside structural repair peptides to analyze systemic anabolic signaling versus localized tissue repair. Understanding these distinct pathways allows laboratories to design well-controlled multi-arm comparative studies.

PX1 Quality Assurance and USA Manufacturing Standards

All PX1 Research compounds are synthesized in state-of-the-art, GMP-compliant facilities located within the USA. We enforce strict quality controls at every step of synthesis, purification, lyophylization, and sterile glass crimping.

Orders are fulfilled quickly with same-day shipping (Monday through Friday) operating directly out of our California and Arizona distribution centers, minimizing environmental exposure and maintaining chain-of-custody integrity for temperature-sensitive research reagents.